Likewise, we recently demonstrated that high PD-L1 expression both in cancer cells and immune cells in TNBC is associated with a favorable prognosis supporting the significance of evaluating PD-L1 status in cancer cells and immune cells in this setting [46]. This evidence concerns the gene CD274 and cancer.